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pre-diluted 1000x in DMSO and added to differentiated TREG cells with a final concentration of 10 nM. 24 h later, cells were harvested for RT-qPCR.
RNA-Seq data analysis
Sequencing reads were aligned to the reference human genome assembly (hg19) using Tophat (1). Only uniquely mapped reads were used for downstream analysis. Mapped reads were assigned to genes and transcripts using Ensembl annotation (GRCh37) (2) and the featureCounts function in the Subread R package (3) . For detecting differentially expressed genes and transcripts, we used EBSeq (4) R package. We computed the pvalues for enrichment of gene ontology terms using hypergeometric test and adjusted for multiple testing using the Benjamini-Hochberg method.
ChIP-Seq data analysis
Sequencing reads were aligned to the reference human genome assembly (hg19) using Bowtie2 (5) with default parameter setting. Only uniquely mapped reads were used for downstream analyses. To obtain normalized ChIP-Seq signal, we first divided the human genome into 200 nt bins and counted the number of uniquely mapped reads in each bin.
The normalized signal of each 200 nt bin was computed as following: For browser display and calculation of histone mark signal, we averaged quantile normalized (6) ChIP-Seq signals across subjects of each cohort (control and case) for each cell type, yielding four merged signal tracks (TH1 control, TH1 case, TREG control, TREG case). For assessing the correlation between the ChIP-Seq data across samples, we quantified the normalized signal in 1000 nt windows and obtained genome wide correlation using Pearson correlation coefficient.
ChIP-Seq peak calling was done using MACS (7) with the default P-value cutoff of 10 -5 and SPP (8) with the z-score threshold of 4.0 (corresponding to P-value 3.2 × 10 -5 ). Only peaks called by both methods (overlap by ³ 1bp) were retained for downstream analysis.
ChIP-qPCR
One million TREG cells differentiated from Foxp3 + -Jurkat cells were crosslinked with 1% formaldehyde at RT for 15 min and quenched with 125 mM glycine. Then cells were lysed and sonicated using Covaris E220 ultrasonicator according to vendor's manual (Covaris). 1% of sheared chromatin was used as the input and the remaining chromatin was subjected to IP using 4 µg of anti-RARA antibody (Santa Cruz, sc-551x) or anti-YY1 antibody (Santa Cruz, sc-7341). Both ChIPed DNA and input DNA were reversed and purified as described in the protocol for low-input ChIP-Seq. qPCR was performed using iQ TM SYBR ® Green Supermix (Bio-Rad) on a Bio-Rad CFX Connect Real-Time system. For each sample, the percentage of input (% input) was calculated as 100x2 (Ct input -6.64-Ct IP ) .
RT-qPCR
Total RNA was isolated using the RNeasy micro kit (Qiagen) including on-column Dnase digestion to remove genomic DNA. cDNA was synthesized from total RNA using the iScript cDNA Synthesis Kit (Bio-Rad) according to vendor's instruction. qPCR reactions were performed on a Bio-Rad CFX Connect real-time PCR system with iQ TM SYBR ® Green Supermix (Bio-Rad) according to manufacturers' instructions. Relative gene expression was calculated using the 2 -ΔΔCt method using ACTB gene as the reference.
SNP genotyping by Sanger sequencing
Input DNA from each individual obtained during the ChIP procedure was used as templates for genotyping using Sanger sequencing. PCR primers, located ≥50 bp upstream or downstream of the target SNPs, were designed using the Primer Premier 5 software. Primer specificity was checked using UCSC in silicon PCR. Sizes of the amplicons were checked by gel electrophoresis and purified using MinElute PCR purification kit (Qiagen) for Sanger sequencing. Sequencing chromatograms were analyzed using the Chromas software (version 2.13) to determine the genotype at the SNP.
Luciferase reporter assay
Candidate enhancer were cloned into the luciferase reporter vector pGL3 (Promega) using In-Fusion HD Cloning Kit (Clontech). A super core promoter 1 (SCP1) (9) was used as the basal promoter. Two negative control regions (~2 kb) with no enhancerassociated histone modification signals in both TREG and TH1 cells were also cloned into the same vector. Reporter constructs with mutations at SNPs were generated using Q5 ® Site-Directed Mutagenesis Kit (NEB) and confirmed by Sanger sequencing. Reporter constructs were co-transfected with the internal control construct pRL-TK (Promega) into Jurkat or Foxp3 + -Jurkat cells using TransIT-Jurkat (Mirus Bio). 24 h post transfection, cells were treated to induce differentiation as described above for 24 h and lysed in 1× passive lysis buffer (Promega) for Dual-Luciferase Reporter Assay kit (Promega). Cells with three independent transfections were harvested after 24 h and measured for firefly and Renilla luciferase activities using the Dual-Luciferase Reporter Assay System
(Promega). Firefly luciferase activity of individual transfections was normalized against
Renilla luciferase activity.
3C-qPCR
3C was performed as described (10) . Briefly, one million TREG cells differentiated from Foxp3 + -Jurkat cells were cross-linked with 4% formaldehyde for 10 min at RT and quenched by adding 0.125 M glycine. Cell pellets were lysed with 1 mL of lysis buffer (10 mM Tris-HCl, 10 mM NaCl, 0.5% NP-40 and 1x protease inhibitor) for 10 min on ice. After centrifugation, nuclei were re-suspended with 450 μL of H2O. 60 μL of 10x restriction buffer for the corresponding enzymes (Dpn II, Hind III and EcoR I) and 15 μL of 10% SDS were added and mixed before incubation at 37 °C with shaking at 1,400 rpm for 1 h. 75 μL of 20% Triton X-100 was added and mixed before incubating at 37 °C with shaking at 1,400 rpm for 1 h. 250 U of restriction enzyme (Dpn II, Hind III and EcoR I) was added and incubated at 37 °C with shaking at 1,400 rpm for 4 h. Additional 500 U of restriction enzyme (Dpn II, Hind III and EcoR I) was added and incubated at 37 °C with shaking at 1,400 rpm overnight. 250 U of restriction enzyme (Dpn II, Hind III and EcoR I) was added and incubated at 37 °C while shaking at 1,400 rpm for 4 h.
Restriction enzymes were heat-inactivated by incubating at 65 °C for 20 min. Digested nuclei were subjected to ligation by adding 30 μL of H2O, 70 μL of 10x T4 DNA ligase buffer and 50 U of T4 DNA ligase (Roche). Ligation was done at 16 °C for 8 h. Ligation products were reverse cross-linked by incubating with proteinase K (NEB) at 65 °C overnight and RNase A (Thermo Scientific) at 65 °C for 30 min. DNA was purified by phenol-chloroform extraction and ethanol precipitation. The concentration of purified DNA was measured using the Qubit dsDNA HS Kit (Invitrogen). 3C standards were generated from BAC DNA as described (11) . Briefly, 10 μg of BAC DNA was digested with 3,500 U of restriction enzymes overnight at 37 °C. DNA was purified using phenolchloroform extraction and ethanol precipitation. Re-suspended DNA was ligated with 50 U of T4 DNA ligase (Roche) overnight at 16 °C. Ligated DNA was purified using phenol-chloroform extraction and ethanol precipitation.
To quantify specific chromatin interactions, normalized relative amount of 3C product was calculated using the following formula: 
Enhancer prediction
Enhancers were predicted using the Chromatin Signature Identification by Artificial Neural Network (CSI-ANN) algorithm (12) . The input to the algorithm are normalized ChIP-Seq signals of two histone marks (H3K4me1 and H3K27ac). The algorithm combines signals of both histone marks and uses an artificial neural network-based classifier to make predictions of active enhancers. The training set for the classifier was prepared using ENCODE data of H1 ESC, GM12878 and K562 cell lines. For positive set of enhancers, we first selected a set of promoter-distal p300 binding sites (2.5 kb away from Refseq TSS) and overlapped them with the histone mark peaks. The top 500 distal p300 sites that overlap with H3K4me1 and H3K27ac peaks, but not H3K4me3 peaks, were selected as the positive set. One thousand randomly selected genomic regions and 500 active promoter regions were used as the negative set. Enhancers were predicted with CSI-ANN using a False Discovery Rate cutoff of 0.05. Predicted enhancers that overlap by at least 500 bp (across groups and cells) were merged by selecting the enhancer with the highest CSI-ANN score.
Prediction of enhancer and promoter interactions
Enhancer-promoter interactions were predicted using the Integrated Methods for Predicting Enhancer Target (IM-PET) algorithm (13) . It predicts enhancer-promoter interactions by integrating four features derived from transcriptome, epigenome, and genome sequence data, including: 1) enhancer-promoter activity correlation, 2) transcription factor-promoter co-expression, 3) enhancer-promoter co-evolution, and 4) enhancer-promoter distance. Here, we used histone modification ChIP-Seq and RNA-Seq data generated in this study to compute values of features 1, 2 and 4 that are specific to TH1 and TREG cells. Values of feature 3 were based on sequence conservation across 15 mammalian species (human, chimp, gorilla, orangutan, gibbon, rhesus, baboon, marmoset, tarsier, mouse lemur, tree shrew, mouse, rat, rabbit, and guinea pig). An FDR cutoff of 0.05 was used as the threshold for making predictions.
Target inference via physical connection (TIPC)
TIPC is motivated by our knowledge about the process of transcriptional regulation by enhancers. It is generally believed that the regulatory process by distal enhancers consists of two key steps, sequence-specific binding of a TF to the enhancer followed by longrange interaction of distal enhancer with target promoter. The mathematical model of TIPC is designed to capture these two key processes. TIPC generates an interaction score for each TF-target pair. This score is the product of three component probabilities, each of which specifically model one aspect of the transcriptional regulation process. The three probabilities are: 1) probability of a DNA sequence being an enhancer, penh; 2) probability of a TF binding to an enhancer given the TF motif model and the enhancer sequence, pTFBS; and 3) probability of enhancer-promoter interaction, pEP.
Calculation of Penh: It is calculated by the CSI-ANN algorithm.
Calculation of PTFBS:
Given the sequence A of an enhancer and the position specific scoring matrix (PSSM) M representing a TF binding motif, the binding probability of the TF to the enhancer sequence can be approximated as following (14):
where l is the length of A and g is the length of the background sequence, Sj is the score of the sequence word starting at position j according to the PSSM, and CTF is the concentration of the TF which we approximate using RNA-Seq data. In this analysis, we used the entire hg19 genomic sequence as the background. We obtained position-specific weight matrices for 1772 TFs from the CIS-BP database (15) Calculation of PEP: It is calculated by the IM-PET algorithm.
We benchmarked the performance of TIPC using a gold-standard set of true positive and true negative TF-target pairs in mouse embryonic stem cell. We used the
ESCAPE database which contains a large amount of gene expression profiling data for
ESCs with either TF knock-down or over-expression and TF ChIP-ChIP/Seq data (http://www.maayanlab.net/ESCAPE/browse.php). We used the following three criteria to curate a set of true positive TF-target gene pairs: 1) the TF and target gene are expressed 2) target gene is differentially expressed in either TF knock-down or TF overexpression experiment; 3) target gene is bound by the TF. The true set consists of 13 TFs, 1303 genes and 5356 TF-gene interactions (Table S16 ). The 13 TFs are ESRRB, KLF4, MYC, MYCN, NANOG, POU5F1, SOX17, SOX2, STAT3, TBX3, TCF3, ZFP281 and ZFX. We generated the same number of true negative pairs by randomly selecting genes that do not satisfy the criterion for true positive pairs. For comparison, we predicted TFtarget interactions using the default parameter settings of other methods (16) .
Identification of key transcription factors
We first constructed transcriptional regulatory network for both cells using the TIPC (described above). To reduce the false positive rate, we filtered the TF-enhancer pairs, so that the enhancer harbors least one significant (p<10 -5 ) binding site for the TF, using fimo (17) . Then we identified key TFs as follows. Our approach is motivated by the notion of information flow in the regulatory network. We assume key TFs tend to propagate their regulatory signal to the largest number of differentially expressed genes in the network, either via direct or indirect connections. Based on this assumption, we computed a distance between two genes, i and j, in the TRN as following:
, where pi and pj are the differential expression p-values for gene i and j, respectively. pmin is the minimum differential expression p-value among all genes in the TRN.
With the distance-weighted TRNs, we calculated median shortest distance between a given TF and all differentially expressed targets (FDR < 0.1) in the network. Statistical significance of median shortest distance was computed using a null distribution computed based on topology preserving randomization, which is obtained by shuffling the edge weights randomly in the network.
Enrichment of T1D associated SNPs in enhancer regions
Enhancers for TH1 and TREG cells are predicted using our epigenomics data and CSI-ANN as described above. For the rest of cell/tissue types, we obtained histone modification ChIP-Seq data from the Roadmap Epigenomic Project Data Portal (18) . We predicted the enhancers in the same way as we did for our data: 1) Mapped the data to the hg19 assembly 2) Filtered the uniquely mapped reads 3) Quantified the reads for each genomic window and normalized by the library size and input control 4) Predicted the enhancer regions using CSI-ANN. Enrichment of T1D associated SNPs overlapping with the enhancers for each cell was computed using hypergeometric test. The total number of SNPs from dbSNP that overlap with enhancers in a given cell type was used as the background.
Calculation SNP and GWAS signal enrichment
We calculated the enrichment of T1D associated SNPs (lead SNP plus linked SNPs) in enhancer regions using both hypergeometric test and LD score regression (19, 20) .
Enhancer were predicted using CSI-ANN and histone mark ChIP-Seq data.
For the LD score regression approach, we obtained genotyping data for T1D case and control subjects (21) from dbGaP (Study Accession: phs000911.v1.p1). We then computed odds ratio for the alleles between case and control and used those to calculate enrichment of GWAS signal in the enhancer regions.
Score for the disruption of transcription factor binding sites by enhancer SNPs
For each enhancer SNP, we first computed two motif scores, one for the sequence containing each of the two alleles of the enhancer SNP. Transcription factor DNA binding motifs were obtained from the CIS-BP database (15) . If at least one of two motif scores has a P-value < 4x10 -7 based on the TFM-Pvalue software (22) , the sequence is considered as containing a binding site for the corresponding TF and retained for further analysis. To compute an empirical P-value for motif disruption, the difference in motif score between the two alleles is compared to a null distribution of motif score differences using randomly selected SNPs from the 1000 Genomes project. Raw P-values were corrected for multiple testing using the Benjamini-Hochberg method. ; ZFX (RPMI-8402, DAOY); RBPJ (CUTLL1, neurosphere); TCF12 (Jurkat, A549); GATA3 (Jurkat, SH-SY5Y); ETS1 (CD4 + C25 + regulatory T cell, A549). For a given TF, we defined its true target genes as those that are nearest to its ChIP-Seq peaks. We then computed the overlap between the TF target set predicted by our method and the TF target set defined by ChIP-Seq data. As a control, we also computed the overlap between TF target set predicted by our method and the target set of the same TF but in a different cell type (mismatched cell). Significance of the overlap was computed using the hypergeometric distribution. Our predictions have significant overlap with TF targets defined by ChIP-Seq in the right cell type (T cell) but not with TF targets in non-T cells. Normalized histone mark signals (H3K27ac and H3K4me1) of the enhancers (1200 bp) were compared across case and control groups and P-values were calculated using the Wilcoxon rank-sum test. Two enhancers that overlap with T1D associated SNPs and have differential histone mark signals (P-value < 0.05) were selected. In addition, three enhancers that do not overlap with any known T1D associated SNP but have differential histone mark signals (P-value < 0.01) were selected.
Fig. S8. Flowchart for the selection of TREG enhancers for follow-up study.
Normalized histone mark signals (H3K27ac and H3K4me1) of the enhancers (1200 bp) were compared across case and control groups and P-values were calculated using the Wilcoxon rank-sum test. All enhancers to be selected overlap with T1D associated SNPs. One enhancer with significant differential histone mark signals for both histone marks was selected (P-value < 0.05). Three enhancers in which the T1D SNPs either disrupt TF binding or overlap with eQTL SNPs and have differential histone mark signal (P-value < 0.05) for one histone mark signal was selected. One more enhancer with differential histone mark signal (P-value < 0.1) for one mark and targets a gene (IL2RA) that has a role in T cell biology was selected.
Fig. S9. Validation of differentiated TH1 and TREG cells using cell-specific marker gene expression. mRNA levels of 3 sets of cell-specific marker genes (TBX21, RUNX3
and IL2 for TH1 cells, GATA3 and CCL1 for TH2 cells, and FOXP3 for TREG cells) were measured by RT-qPCR in differentiated TH1 (a) and TREG cells (b). Undifferentiated Jurkat and Foxp3 + -Jurkat cells were used as controls for TH1 and TREG cells, respectively. mRNA levels were normalized to TBP (TATA box binding protein) gene. Data shown are mean + SEM of two biological replicates.
Fig. S10. Genome Browser view of additional validated enhancers in TREG. (a)
Genome browser tracks for the enhancer located at chr10: 6094400 -6096600 (highlighted in yellow), including normalized histone modification ChIP-Seq signals, RNA-Seq signals of target genes of the enhancer, enhancer-promoter interactions predicted by IM-PET algorithm, supporting capture-Hi-C data (Javierre et al 55 ) for the enhancer-promoter interaction (if any) and SNP locations. In addition, TF motif and binding sites (if any) that are significantly affected by the SNP(s) are also shown. The SNP rs10795763 perturbs the binding site of MITZ (BH-adjusted P-value = 0.02. D', measurement of linkage disequilibrium between the enhancer SNP rs10795763 and the lead T1D GWAS SNP rs61839660 (shown in red). (b) Enhancer located at chr14: 68757800 -68760200 targeting the ACTN1 gene. The enhancer SNP rs35763290 perturbs the binding site of NRF1 (BH-adjusted P-value = 0.06). D', measurement of linkage disequilibrium between the enhancer SNP rs35763290 and the lead T1D GWAS SNP rs911263 (shown in red). (c) Enhancer located at chr1: 200830000 -200832000 targeting the PHLDA3 gene. 
